Status:

WITHDRAWN

Performance Evaluation of SARS-COV-2 (Covid-19) Antigen Rapid Test

Lead Sponsor:

Sky Medical Supplies & Equipments, LLC

Conditions:

SARS-CoV-2

Covid-19

Eligibility:

All Genders

Phase:

NA

Brief Summary

The SARS-CoV-2 Antigen Rapid Test is a bioassay intended for rapid point-of-care detection of the SARS-CoV-2 virus. Performance of the SARS-CoV-2 Antigen Rapid Test assay will be assessed by compariso...

Detailed Description

The clinical performance of the SARS-CoV-2 Antigen Rapid test was evaluated in a prospective clinical study conducted at a single (1) CLIA waiver investigational site in Miami, Florida, U.S. Consentin...

Eligibility Criteria

Inclusion

  • 1\. Up to 200 subjects will be screened, consented, and enrolled to obtain a minimum of 60 eligible candidates. In order to be eligible to participate in this study, an individual must meet all of the following criteria:
  • Provision of informed consent
  • Subject is a suspected case of COVID-19 by clinical criteria: a patient with acute respiratory tract infection (sudden onset of at least one of the following: cough, fever, shortness of breath, fatigue, decreased appetite, myalgia) AND with no other etiology that fully explains the clinical presentation, with or without a history of close contact with a confirmed or probable COVID-19 case in the 14 days prior to onset of symptoms.
  • Subject is an appropriate candidate for Nasopharyngeal sample collection. d/. Subject is willing to provide nasopharyngeal swab samples.

Exclusion

  • An individual who meets the following criterion will be excluded from participation in this study:
  • 1\. Individuals who present with 10 or greater days of COVID-19 Related Symptoms, (Fever, Cough, Fatigue, Decreased Appetite, Shortness of Breath, Myalgia) or post-defervescence and/or convalescence.

Key Trial Info

Start Date :

January 9 2021

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

January 28 2021

Estimated Enrollment :

Patients enrolled

Trial Details

Trial ID

NCT04808921

Start Date

January 9 2021

End Date

January 28 2021

Last Update

August 5 2022

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

D&H National Research Centers INC

Miami, Florida, United States, 33155

Performance Evaluation of SARS-COV-2 (Covid-19) Antigen Rapid Test | DecenTrialz